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The Consortium of Radiologic Imaging Studies of Polycystic
Kidney Disease (CRISP) recently showed that renal
enlargement in autosomal-dominant polycystic kidney
disease mimicked exponential growth. We determined the
effects of cyst initiation rate, total number, and growth rate
on the time-dependent change of total cyst volume (TCV).
Mathematical models with equations integrating cyst surface
area, volume, and an invariant growth rate constant were
used to compute the time-dependent change in volume of
solitary and multiple cysts. Multiple expanding cysts
increased TCV in an exponential-like pattern even when
individual cysts formed at different rates or exhibited
different but constant growth rates. TCV depended on the
rate of cyst initiation and on the total number of cysts;
however, the compounding effect of exponential-like growth
was the most powerful determinant of long-term cyst
expansion. Extrapolation of TCV data plots for individual
subjects back to an age of 18 predicted TCV values within an
established range. We conclude that cysts started early in life
were the main contributor to eventual TCV while their
growth rate primarily determined renal size; although the
rate of formation and the ultimate number of cysts also
contributed. The good fit between the exponential models
and the extrapolated CRISP data indicates that the TCV
growth rate is a defining trait for individual patients and may
be used as a prognostic marker.
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The progressive expansion of renal cysts is the hallmark of
autosomal-dominant polycystic kidney disease (ADPKD).1,2
At the end stage, ADPKD kidneys are distorted masses of
fluid and blood-filled sacs embedded within dense fibrotic
bands. Cyst initiation begins early in life in a relatively small
fraction of renal tubules when the levels of functional
polycystin-1 or polycystin-2, the proteins encoded by PKD1
and PKD2, decrease below a critical threshold.3–7 Fluid-filled
cysts, often several centimeters across, extend from renal
tubules normally 20–40 mm in diameter. The cyst-forming
process appears to continue over the life of the individual.8
Cystogenesis involves focal and sustained proliferation of
tubule epithelial cells, creating a mural pocket that progres-
sively expands. Initially, glomerular filtrate enters the focal
hyperplastic tubular segments to create microscopic cysts.
When they reach B2 mm in diameter (B0.0042 cm3), most
cysts separate from the parent tubule to become isolated
sacs.9 The sacs continue to expand as mural cell proliferation
is compounded by transepithelial chloride secretion and
osmotic water flow sufficient to fill the potential cavity
created by the segmental neoplasm.10
The number of cysts that develop and their locations differ
among patients as does the rate of cell proliferation. Cysts
form in the cortex and the medulla, and in the early stages
they may be scattered from pole to pole or sequestered in
regions of the kidneys suggesting a haphazard process of
initiation. In view of the biologic similarities between renal
cyst enlargement and the growth of benign solid tumor
masses, it was suggested that ADPKD might follow a
relatively predictable course.11,12 An observational study of
232 patients with non-azotemic ADPKD (Consortium of
Radiologic Imaging Studies of Polycystic Kidney Disease,
CRISP) involving five academic medical centers was designed
to ascertain the extent to which disease progression, reflected
in the aggregate volumes of kidneys and cysts, was orderly or
chaotic.13 The study dramatically established that combined
kidney volume (leftþ right) increased in 93% of the patients
over a 3-year period and that the increase in total kidney
volume (TKV) was equal to the increase in total cyst volume
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(TCV), confirming that the increase in size can be ascribed
primarily to the increase of fluid-filled cysts.
There was a wide range of age-adjusted kidney volumes
among patients in the CRISP study and the intrarenal
distribution of individual renal cysts was haphazard,
probably reflecting the random expression of the ‘second
hits’ or somatic events that initiated cyst formation.14–16
Surprisingly, the subsequent enlargement of the cysts in the
CRISP study appeared to be predictable within individual
subjects. Semi-logarithmic plots of TCV and TKV versus time
were linear suggesting that renal growth was exponential,
similar to the growth of individual cysts formed by renal
epithelial cells in culture17–19 (Figure S1). The purpose of this
study was to reconcile the apparently chaotic process of cyst
initiation and intrarenal cyst distribution with the orderly
renal enlargement. We utilized multicyst mathematical
models to investigate the independent and interactive effects
of (1) the chronological initiation of cysts, (2) the number of
cysts, and (3) the growth rates of individual cysts on the
time-dependent patterns of increased TCV.
RESULTS
In ADPKD, the consensus holds that cysts derive from one or
a few mural epithelial cells within a renal tubule segment that
become genetically transformed to proliferate indefi-
nitely.14,15 These partially dedifferentiated cells cause an
expansion of the tubule wall lined by a single layer of
epithelium that retains certain structural, and electrolyte and
fluid transport features of the parent nephron. The expand-
ing segment eventually separates from the parent tubule,
leaving an isolated sac that fills with fluid secreted by the
epithelium.20
To model renal cyst growth, we assumed that a tubule
pocket becomes a sphere (cyst) when it detaches from the
parent tubule. Mural cell proliferation is the principal factor
leading to the enlargement of renal cysts.11 Fluid secretion
has been demonstrated in normal renal tubules and in renal
cyst epithelium;21,22 however, fluid secretion does not
contribute to the initiation of cysts as the dilated tubular
segment is contiguous with the nephron (Figure 1). It is only
after the cyst detaches from the parent tubule that fluid
secretion contributes substantially to the accumulation of
liquid within the cyst cavity to fill the expanse created by
mural hyperplasia.
Hydrostatic pressures within cysts remain close to values
observed across the walls of normal renal tubules, indicating
that a balanced state develops between the proliferation and
the fluid secretion components of cyst enlargement.23,24 The
weight of current evidence supports the view that cellular
proliferation is the principal controlling element determining
how fast renal cysts will expand, with fluid secretion having a
lesser role.25 Consequently, the most economical model of
cyst enlargement supposes that the rate of cell proliferation
minus the loss of cells through apoptosis determines the size
of the cyst and that fluid secretion increases proportionate to
the net increase in mural epithelial area.
Cyst growth models
Solitary cyst. To simplify analysis, we assume that a cyst is
formed when it separates from the original tubule
(0.0042 cm3) (Figure 1). We assume further that the cyst
remains spherical by the addition of uniform cellular
elements that follow uniform growth kinetics. The mural
epithelium remains confluent and the lumen expands to the
fullest extent, dependent only on the number of cells
increasing at a constant rate. This net growth rate will
depend on the relative rates of proliferation and apoptosis,
which for simplicity are not considered separately.
Assuming that isolated cysts enlarge as spheres,
VðtÞ ¼ V0e
3k0t
2
where
V0 ¼ ð 1
6
ﬃﬃﬃ
p
p A3=20 Þ
and V(t) is the cyst volume (cm3) at time t (years), V0 is cyst
volume at baseline, A is epithelial apical surface area (cm2),
and k0 is the epithelial growth rate constant (proportion per
year). The relation between cyst volume and time has an
exponential form (Appendix 1). This approach is based on
Salt
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Figure 1 | Schematic diagram illustrating the evolution of a spherical cyst from a renal tubule.
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assumptions similar to those used to quantify the doubling
times and growth rates of solid pulmonary tumors.26
Shown in conventional format in Figure 2a are the
hypothetical relations between volume and time for solitary
cysts beginning at a volume of 0.0042 cm3 and growing at
constant rates set by k (5–25% per year; k¼ 3k0/2).
Logarithmic transformation of the data in Figure 2a would
yield linear plots, similar to that shown for in vitro cysts
(Figure S1). Figure 2a also illustrates the remarkably
important effect of mural growth rate on cyst volume. It is
instructive to note that the volume of a cyst growing at 5 or
10% per year would be o1 cm3 after 50 years. However, as
mean growth rates increase above 10%, there are astonishing
increases in cyst size owing to the compounding effect of
exponential growth. Figure 2a illustrates that mean indivi-
dual cyst growth rates exceeding 20–25% per year would be
required to account for cysts that exceed 1 cm3 volume in
patients with ADPKD less than 25 years of age.
Multiple cysts initiated at a single uniform time. Suppose
that all of the cysts were to initiate at a common time in utero
or post partum and, reaching 0.0042 cm3 volume or there-
abouts, separate from the tubule of origin. Assuming that
subsequent enlargement was dependent only on mural cell
proliferation, the TCV would be the sum of individual cyst
volumes (Vi),
TCV ¼
Xn
i¼1
Vi
Figure 2b illustrates the uniform expansion of 500 individual
cysts initiated on a common date (baseline) and growing over
several years at the same rate. Non-cystic parenchyma and the
collecting system are not considered in the model. Figure 2b
illustrates that multiple cysts growing at the same rate
ranging from 5 to 25% per year retain the exponential form
shown in Figure 2a for solitary cysts.
Continuous formation of cysts with a constant growth
rate. Computed tomography scan measurements in
ADPKD confirm that the volumes of small and large
individual cysts increase with advancing age.27 Finding tiny
cysts among large cysts at any stage of the disease suggests
that cyst formation continues as patients age, a view
supported by a recent extension of the CRISP study.8
Heterogeneous, not uniform, distribution of cyst sizes is
the typical pattern observed in computed tomography and
magnetic resonance scans of most adult ADPKD patients.28,29
Consider that for several cysts starting at different times
with individual volume growth rates of k, the composite rate
of increase in V is piecewise exponential,
VðtÞ ¼ CnðtÞekt
where the factor Cn(t) depends on start times and initial
volumes of cysts and is defined in Appendix 2. The effect on
TCV of the annual addition of 40, 80, or 160 cysts, each
enlarging at a rate of 10% per year, is illustrated in Figure 3a.
As in previous examples, the curves have an exponential form
and further, assuming similar and constant rates of individual
cyst growth, indicate that kidneys with the most rapid rates of
cyst formation are fated to swell at the fastest rates.
Cyst number. The number of cysts in a polycystic kidney
is an important determinant of how large the organ may
To
ta
l c
ys
t v
ol
um
e 
(cm
3 )
0
1000
2000
3000
4000
5000
Years
10 20 30 40 50
Years
10 20 30 40 50
So
lita
ry
 c
ys
t v
ol
um
e 
(cm
3 )
0
5
10
15
20
25
5
10
15
20
25
5
10
15
20
25
Figure 2 | Dependence of solitary cyst and multiple cyst
enlargement on proliferation (growth) rate with k varying 5–25%
per year. (a) Solitary cyst. (b) 500 cysts initiated at a common time
and growing at a constant rate. In this and subsequent figures, the
initial cysts have a diameter of 2 mm (0.0042 cm3).
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Figure 3 | Dependence of combined cyst enlargement on time of initiation and variable growth rates of individual cysts. (a) Appearance
of kidney enlarged by cysts initiated on different dates and growing at the same rate. TCV time course patterns when 40, 80, or 160
cysts are initiated each year and grow at 10% per year. (b) Effect of different cyst growth rates (k¼ 2.5, 5, 7.5% per year) on configuration
of TCV growth curves. All cysts initiated on uniform date, t¼ 0; 5000 cysts divided equally among three growth rates. Composite curves
include all three growth rates. (c) Cysts added at a constant rate for 50 years up to a total of 5000 cysts, growing at three different growth rates
(k¼ 2.5, 5, 7.5% per year). Ordinate values for C are the same as for B. Composite curves include all three growth rates.
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eventually become. As shown in Figure 3a, at age 50, there are
more cysts in the kidneys generating them at the rate of 160
per year (8000 total) and the kidneys are larger, than in the
kidney generating cysts at 40 per year (2000 total). And
irrespective of whether or not cyst number increased
continuously, the relation between TCV and age retained an
exponential form.
Continuous formation of cysts with varying growth rates. It
is unlikely that all cysts within a polycystic kidney grow at the
same rate. Each cyst represents the clonal growth of cells with
distinct genetic and phenotypic characteristics. Suppose that
cysts generated on a uniform date exhibit different individual
rates of constant growth, then;
TCVðtÞ ¼ V0
Xn
i¼1
ekit
where ki is the growth rate constant for the ith group of cysts.
In Figure 3b, 5000 cysts were equally divided into three
groups (1666 each), initiated on a uniform date, t¼ 0, with
constant individual cyst growth rates of 2.5, 5.0, and 7.5%
per year. TCV was greater than 0 since the volume of each of
the 5000 individual cysts was 0.0042 cm3 initially. Each
growth rate generated a unique curve with an exponential
form, and the composite of all growth rates mimicked an
exponential as well. This illustration reiterates that cyst
growth rate is a powerful determinant of TCV as the
composite curve incorporating all three rates of growth was
dominated by the cysts growing at the fastest rate, 7.5%
per year.
In the next iteration, three equal groups of cysts (1666
each) were generated at a constant tempo from age 0 to 50
years, each growing at constant rates of 2.5, 5.0, or 7.5% per
year. As seen in Figure 3c, the relation between TCV and age
for each cyst growth rate was curvilinear, and the composite
of all three growth rates mimicked an exponential as well.
After 50 years, TCV in Figure 3b was higher in each case than
in Figure 3c because there were more cysts.
Punctuated cyst formation. In the previous models, cyst
initiation was viewed as either an all or none embryonic event
or as a process in which cysts were continuously added
throughout life. In the light of the underlying assumptions,
in both of these cases exponential-like enlargement of TCV
was expected. However, cysts might initiate in bursts, rather
than being evenly paced throughout life. Thus, we analyzed
TCV in a case in which an acquired event forced a large wave
of cyst formation at 30 years of age. Figure 4a illustrates a
kidney in which 2000 cysts were initiated at t¼ 0 (solid line)
and another kidney in which 1800 cysts were initiated at t¼ 0
and 200 were added at 30 years of age (dotted line). The
punctuated addition of 200 cysts had minimal impact
because of the overwhelming effect on volume of cysts that
had been enlarging for 30 years.
Conversely, Figure 4b shows the effect of initiating 200
cysts at t¼ 0 and the addition of 1800 cysts at 30 years of age
(dashed line) compared to the effect of 2000 cysts initiated at
t¼ 0 (solid line). The punctuated addition of a large number
of cysts created a small discontinuity in the TCV growth
curve; however, in a practical case, the change in slope would
probably be obscured since the superimposition of a
relatively small volume increase would be difficult to detect
in the noise of the clinical measurement and the growth
curve would appear exponential. Thus, punctuated cyst
formation would not have a significant effect on the
appearance of the TCV growth curve.
Effect of cyst loss. One must also consider the life span of
individual cysts and the contribution that cyst collapse may
make to the relation between TCV, TKV, and age. Cysts are
known to rupture and decompress in patients with ADPKD
and this might contribute to momentary changes in the rate
at which TCV and TKV increase. Experience with the CRISP
cohort indicates there is a very small rate of cyst loss in
ADPKD. Consequently, we do not think that cyst loss
contributes appreciably to the configuration of the TCV and
TKV growth curves and we have not included a cyst-loss
function in the model.
A test of exponential cyst and kidney growth in the CRISP
cohort
In the initial CRISP study, three or four cyst and kidney
volume measurements were made over a 3-year interval in
most subjects. Examination of the relation between volume
and time for the entire cohort gave the impression that the
course of size progression was exponential (Figures 5a and
6a).13 To test this hypothesis, we analyzed the TCV and TKV
growth curves of 224 ADPKD patients in the CRISP study to
determine the extent to which renal growth in each CRISP
patient mimicked an exponential form. We logarithmically
transformed the TCV and TKV versus time data and
determined the extent to which the volume intercept at age
18, an age that renal developmental growth normally stops,
agreed with a data set from 18-year olds with ADPKD. We
established the target 18-year-old ‘window’ of the intercept
by determining TCV and TKV for 21 CRISP subjects who had
18-year-old birthdays while in the study. TCV and TKV were
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Figure 4 | Punctuated cyst formation. (a) Solid line, 2000 cysts
initiated at t¼ 0. Dotted line, 1800 cysts initiated at t¼ 0 and 200 at
age 30. (b) Solid line, 2000 cysts initiated at t¼ 0; Dashed line, 200
cysts initiated at t¼ 0 and 1800 more added at 30 years of age.
Dotted line extends 200 cyst plot. All cysts grew at 10% per year.
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determined by log linear regression for each subject. Mean
TCV was 2227187 cm3, range 2.8–692 cm3 and mean TKV
was 6437257 cm3, range 276–1341 cm3. These 21 subjects
were not included in the subsequent analysis.
We examined in conventional form curves derived from
logarithmic transformed TCV time-course plots extrapolated
from age 50 to 18 in 203 subjects in whom at least three
annual volume measurements were made (Figure 5). The
original plots of TCV versus age, determined from T2-
weighted magnetic resonance images, are shown in Figure 5a
and the extrapolated curves are shown in Figure 5b. The
intercepts of 188 of 203 (92.6%) extrapolated curves fell
within the window (2.8–692 cm3) set by the18-year-old
subjects. The intercepts of 10 fell above this window and 5
fell below. The mean intercept with the TCV axis at age 18 of
the 203 subjects was 221 cm3, which agrees favorably with the
mean of measured TCV in 21 subjects (222 cm3). This finding
is consonant with the view that in most ADPKD patients, the
expansion of TCV follows an exponential-like growth pattern
over the adult portion of life.
We sought further confirmation of this finding. The
measurement of TKV in CRISP utilized the T1 magnetic
resonance format, and therefore yielded growth data
independent of the TCV determinations. Analysis of the
TKV data is complicated, however, by the inclusion in the
measurement of a relatively large non-cyst component
ascribed to normal parenchyma, vasculature, and the
intrarenal collecting system. Evidence from CRISP13 and a
recent computed tomography study30 indicated that this
non-cyst component may decrease slightly over time, but that
the absolute change would be relatively small. Thus, we
considered that TKV¼TCVþNCV, where NCV (non-cyst
volume) is a constant, and TKV would increase pari passu
with TCV. On this basis, we determined how closely the
extrapolation of logarithmically transformed TKV data in
CRISP approximated the TKV intercept target set by 18-year-
old subjects with ADPKD. As shown in Figure 6b, 72.9% of
the TKV intercepts of 203 subjects fell within the TKV
window (276–1341 cm3) set by the 18-year-old CRISP
patients. The intercepts of six fell above this window and
49 fell below. The mean intercept with the TKV axis at age 18
of the 203 subjects was 540 cm3 in comparison to the actual
measurements in 21 subjects, 643 cm3. The slopes of 14
subjects were slightly negative, although most of these were
indistinguishable from a slope of 0.
DISCUSSION
Cyst formation within a morphologically normal segment of
renal tubule appears to be a multistep process. The first step
commences with the inheritance of a mutated PKD1 or PKD2
gene or upon spontaneous mutation of a PKD gene within
the fertilized germ cell. The second step requires a somatic
mutation of the normal ADPKD allele or the imposition of
another constitutively active process that causes focal
transformation of individual renal tubule epithelial cells to
a proliferative phenotype. The ultimate size of the kidneys is
determined by the pace at which cysts are formed, the total
number of cysts, and most important, the rate of net cellular
growth within the individual cysts.
The results of the current analysis focused on the early
stages of cyst and kidney growth before the imposition of
scarring and other secondary effects. The absolute number of
cysts and their rate of formation are obviously important
determinants of the rate of disease progression and are
potential targets for therapeutic intervention. In the CRISP
cohort, the kidneys of individuals with PKD1 were 47%
larger than the kidneys of patients with PKD2.8 However, the
mean rates of TCV and TKV growth were not significantly
different between the PKD1 and PKD2 subgroups suggesting
that PKD1 kidneys harbored more cysts than PKD2 kidneys.
Direct counting confirmed that 64% more cysts were found
in PKD1 kidneys than in PKD2 kidneys.
Although cyst number is important, disease morbidity is
directly related to cyst enlargement. The current study brings
into clearer view the remarkable power of cellular prolifera-
tion and cyst growth rate on the speed of renal enlargement.
Figure 2a illustrates the mean rate of growth for solitary cysts
at any point in time. Assuming formation in the embryonic
period, a cyst 2 cm in diameter (4.2 cm3) in a 25-year-old
patient would reflect a mean growth rate of B25% per year;
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Figure 5 | Time-course plots of TCV growth curves. (a) Original TCV
data from CRISP cohort. (b) Curves extrapolated from 3 to 4
measurements over 3 years in 203 CRISP patients. The intercept
window of TCV determined in 21 subjects at 18 years of age
(2.8–692 cm3) is shown by horizontal lines.
Years
20 30 40 50
Years
20 30 40 50
To
ta
l k
id
ne
y 
vo
lu
m
e 
(cm
3 )
0
1000
2000
3000
4000
5000
Figure 6 | Time-course plots of TKV growth curves. (a) Original TKV
data from CRISP cohort. (b) Curves extrapolated from 3 to 4
measurements over 3 years in 203 CRISP patients. The intercept
window of TCV determined in 21 subjects at 18 years of age
(276–1341 cm3) is shown by horizontal lines.
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in a 45-year-old patient a 2 cm cyst would reflect a mean
growth rate closer to 15% per year. By contrast, cysts growing
at 10% per year or less would not reach 1 cm3 in volume in 50
years. Furthermore, it is instructive to compare the relative
effects of cyst number and cyst growth rate on the change in
TCV. Doubling the number of new cysts from 40 to 80 per
year increased TCV from 213.6 to 427.1 cm3 at age 50, that is
doubling the number of cysts doubled the TCV (Figure 3a).
By contrast, a doubling of the cyst growth rate from 5 to 10%
per year increased TCV from 25.5 to 310.8 cm3 at age 50, a
12.1-fold difference (Figure 2b). Thus, the power of
exponential compounding elevates cyst growth rate as a
critical factor in the determination of TCV and TKV.
A major goal of the current study was to develop a
rationale for testing the hypothesis that the composite rate of
total cyst growth in ADPKD patients reflects an exponential
growth process originating in individual cysts. We demon-
strated in models that as long as individual cysts grew at a
relatively constant rate, kidneys comprised of innumerable
cysts initiated at different times and growing at different rates
would exhibit composite cyst growth curves resembling
exponential form. In other words, the rate of cyst growth was
dependent to a major extent on the growth rate of the mural
epithelium within them. To test this hypothesis, we adopted
the simplest model by assuming that cyst volume was
0.0042 cm3 at initiation, the cysts remained spherical and
enlarged at a constant rate over the life of the patient. We
formally tested the hypothesis utilizing data from the CRISP
cohort comprised of individuals with normal glomerular
filtration rate levels on admission, none of whom developed
renal insufficiency in the course of the study.
We were surprised to discover that reverse extrapolation of
cyst volume data predicted TCVs at age 18 that in most of the
subjects fell within a range predicted by direct measurements
in a separate cohort of patients (Figure 5b). This finding was
aided by the fact that the correlation between TCV and time
in the vast majority of adults was excellent, consistent with an
orderly expansion process. The kinetic analysis of TCV was
supported in the contemporaneous measurements of TKV by
an independent method. Reverse extrapolation of the TKV
intercepts fell within the 18-year-old target in a sizable
majority (Figure 6b). The exponential-like form of the
extrapolated TKV plot in Figure 6b suggests that the
principal non-cyst components of TKV (normal parenchy-
ma, collecting system) remains relatively constant and that
the exponential-like form is primarily due to the changing
volume of the cystic component. Taken together, these
findings, and the prior observation that kidney pairs of
individual patients enlarged at approximately the same
rate,2,13 provides strong support for the view that cystic
kidneys are comprised of autonomous cysts subject to a type
of ‘programmed’ growth.
We have also learned that as long as individual cysts in a
kidney grow at a relatively constant mean rate, the
exponential character of the TCV growth curve is maintained
even if cysts are added continuously or in boluses. Within
these constraints, cysts may grow at different rates, yet in the
aggregate they will generate a TCV time course that appears
exponential. The exponential form of the renal growth curves
is important because it strongly indicates that the change in
cyst and kidney volume is dependent upon the sustained
increase in cyst mural epithelial cells. Welling and Welling31,32
demonstrated that cyst expansion tied only to distention of
the renal tubule with fluid would reach a saturation point
when tubule diameter reached B200 mm. Thus, the accu-
mulation of fluid derived from the glomerular filtrate or
secreted by the mural epithelial cells would be insufficient
alone to cause expansion of the tubules to several centimeters
in diameter. Rather, new cells and tubule basement
membrane would have to be added to create a macroscopic
cyst. In a scanning electron microscope study of cyst apical
surfaces, evidence was found that tiny and large cysts were
comprised of mural cells approximately the same size as
normal tubule epithelial cells, reinforcing the hypothesis that
renal cysts were products of neoplasia.10
In the CRISP study, mean rates of TCV change reached as
high as 44% per year consistent with doubling inB1.6 years.
Although this may seem rapid in the context of renal
enlargement, the doubling time is excessively long when
viewed in relation to the growth of renal cells in vitro or
malignant tumors in situ. Cysts generated from ADPKD
mural cells and MDCK cells in hydrated collagen gels double
their volume in approximately 24–36 h when stimulated with
cyclic AMP agonists,18,19 approximately two orders of
magnitude faster than the most rapidly expanding mean
TCV in CRISP. When one considers that most of the volume
of cysts is fluid rather than cells, the gap between the growth
of the mural cells lining cysts and the cells comprising solid
tumor masses is emphasized further. Additionally, owing to
geometry, the growth rate reflected in the change of cyst
surface area would be reduced by 33.3% in comparison to
cyst volume. Thus, the rate of mural epithelial cell growth
mirrored in the cyst volume growth curves is very slow in
comparison to malignant disorders such as bronchogenic
carcinoma26 and renal cell carcinoma.33
Figures 5 and 6 show that the rates of increase in TCV and
TKV varied widely among individual patients, but remained
relatively constant within individual subjects. Thus, each
patient appears to have a ‘signature’ rate of cyst and kidney
growth. How a similar and relatively constant mean rate of
TCV growth is maintained in both kidneys is not known;
however, several factors should be considered: (1) in
individual patients, all cysts might grow at the same rate,
the difference in cyst size reflecting different initiation dates.
This seems unlikely since the direct measurement of
sequential cyst diameters in computed tomography scans
from a few subjects do not appear to support such a
mechanism;27 (2) the range of basal cell growth rates among
cysts within ADPKD kidneys may be determined by genetic
factors other than PKD1/PKD2 mutations and reflected in
the mean rate of TCV; (3) the older cysts will dominate TCV
and TKV, obscuring contributions to growth of smaller cysts.
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This may be the case in those kidneys with low rates of cyst
initiation and relatively few cysts but is an unlikely
explanation in kidneys containing myriads of cysts less than
1 cm in diameter; and (4) cyst growth may be ‘clamped’ by
hormones or autocoids that activate adenylyl cyclase to
synthesize cyclic AMP. There is abundant new evidence to
indicate that cyclic AMP importantly regulates the rate of cell
proliferation and fluid accumulation in renal cysts of patients
with ADPKD and ARPKD.34–37 Adenylyl cyclase is activated
by vasopressin in response to changes in water balance.
Normal persons, who are naturally antidiuretic, have plasma
levels of vasopressin that persistently activate adenylyl cyclase.
Only when large volumes of liquid are consumed, usually
over short intervals of time, do plasma vasopressin levels
decrease enough to render the urine more dilute than plasma.
Thus, patients are under the influence of vasopressin most of
the day and cyst epithelial cells are persistently stimulated to
proliferate.
A body of evidence supports the hypothesis that cyst
formation and expansion are largely responsible for the
eventual decrease in GFR experienced by most patients with
ADPKD.2,13 The fluid within the cyst cavity occupies
important space and potentiates the rather slow rate of
orderly proliferation by creating a tumor that is much larger
than the combined mass of the proliferating cells. Whether
the decreases in renal blood flow and glomerular filtration
rate are mediated simply by the mechanical distortion and
disruption of the intrarenal microcirculation or is due to
unrecognized genetic factors is not known. What we do know
is that patients with PKD1 develop renal insufficiency
approximately 14–20 years earlier than those with PKD2.38
In the CRISP study, age-adjusted PKD1 subjects had larger
kidneys containing more cysts than individuals with the
PKD2 genotype.8 Conceivably, the reduced number of cysts
might assuage the development of renal insufficiency by
causing less distortion of the normal parenchyma between
the cysts. Women with PKD2 appear to have a relatively low
risk for developing end-stage renal disease.39 This may reflect
the combined effect of a lower number of cysts associated
with PKD2 mutations and slower cyst growth in females,8
and is consistent with the potential stimulatory effect of
testosterone on cyclic AMP accumulation.40
In summary, this study improves our understanding of the
relative roles played by cyst initiation, cyst number, and cyst
growth in the creation of an expanding polycystic kidney.
Our data indicate that the exponential form displayed by
kidney volume change over time is the summative reflection
of the aberrant cell proliferation and complementary fluid
secretion going on in hundreds of cysts. The individual
growth rates of solitary cysts can be approximated by
determining volume from diameter. Cyst growth rates
exceeding 10% per year are associated with more rapid increases
in TCV and TKV. This study strengthens the view that
sequential measurements of kidney volume and cyst volume
and number will report the efficacy of therapeutic agents
targeted to decrease the rate of mural cell proliferation.
MATERIALS AND METHODS
A portion of this study is based on the analysis of mathematical
models of multiple conjoint cysts as a means of establishing the
justification for a re-examination of data from the CRISP study of
human subjects with ADPKD and normal glomerular filtration rate
at enrollment into the study.13 Of a total of 241 patients, in 232
patients without azotemia who were 15–46 years old at baseline,
annual changes in TCV and TKV were determined for 3 years. The
methods used in CRISP to obtain images and to determine TCV and
TKV (left and right volumes were combined) from those images
have been reported in detail.1,29 In the current analysis, we included
only those CRISP patients in whom three or four annual
measurements had been done (224 patients).
Only descriptive statistics were used in this study.
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Appendix 1
Assume a cyst is a sphere, then for radius r, surface area
A, and volume V, we have A¼ 4pr2, V¼ (4/3)pr3, and
V ¼ 1
6
ﬃﬃ
p
p A3=2. A cyst grows because of cell proliferation
according to the relationship below:
dA
dt
¼ k0A
where A is the surface area of the cyst, A0 is its surface area at
time t¼ 0, and k0 is the rate constant (fractional growth of
surface area per unit time). Solving for the function A, we
obtain the following:
AðtÞ ¼ A0ek0t
Using the relationships above,
VðtÞ ¼ 1
6
ﬃﬃﬃ
p
p ½AðtÞ	3=2
¼ 1
6
ﬃﬃﬃ
p
p ½Aek0t 	3=2
¼ ð 1
6
ﬃﬃﬃ
p
p A3=20 Þ½ek
0t 	3=2
¼ V0eð3k0tÞ=2
Thus the volume of a spherical cyst grows exponentially with
a growth rate of k¼ 3k0/2, where V0 ¼ ð 16 ﬃﬃpp A3=20 Þ.
We note that exponential growth in any one of the
geometric attributes of a sphere, for example, radius, surface
area, or volume, implies exponential growth in the other
elements. The corresponding growth rates of the surface and
the volume are related as shown above, while the rates for the
radius and the surface are related as kradius¼ k0/2.
Appendix 2
Assume each cyst is growing at a constant rate, k, with start
volume V0 (2 mm diameter), and with random start times ti
(for cyst i). Each individual cyst grows according to the
following equation:
ViðtÞ ¼ V0UðtiÞekðttiÞ;
where U(ti)¼U(tti) is the unit step function, i.e., U(t)¼ 0
if to0, and U(t)¼ 1 if tX0.
The total volume of cysts growing at a constant rate, k,
with varying start times, ti, is given by
VðtÞ ¼
Xn
i¼1
V0UðtiÞekðttiÞ:
Rewriting, we have
VðtÞ ¼
Xn
i¼1
ektV0UðtiÞekti
¼ V0
Xn
i¼1
UðtiÞekti
 !
ekt
¼ CnðtÞekt
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where
CnðtÞ ¼ V0
Xn
i¼1
UðtiÞekti
 !
is a step function. Thus, the TCV is given by
VðtÞ ¼ CnðtÞekt ;
and the growth function is a simple exponential on each
interval of time between the initiation of cysts, that is, for t
satisfying tiptotiþ 1, where i ranges from 1 to n1. The
function Cn(t) is a step function, and the effect of adding a
new cyst is to shift the entire volume curve upward. The
resulting total volume curve is a piecewise exponential
function with a discontinuity at the initiation of each cyst.
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of Polycystic Kidney Disease (CRISP) study were as follows:
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VE Torres, AB Chapman, LM Guay-Woodford, KT Bae,
PC Harris, CM Meyers, JP Miller, WM Bennett, S Klahr,
DA Baumgarten, PJ Kenney, X Zhang, and F Zhu; Data
and Collection and Analysis—JJ Grantham, VE Torres,
AB Chapman, LM Guay-Woodford; Radiologic Analysis—
KT Bae, BF King, LH Wetzel, PJ Kenney, DA Baumgarten;
Biostatistics—JP Miller, X Zhang; JE Bost, Design
and Supervision and Analysis of MRI Protocol—KT Bae,
F Zhu.
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